[go: up one dir, main page]

AU8136801A - Methods of preventing or treating diseases and conditions using complex carbohydrates - Google Patents

Methods of preventing or treating diseases and conditions using complex carbohydrates

Info

Publication number
AU8136801A
AU8136801A AU8136801A AU8136801A AU8136801A AU 8136801 A AU8136801 A AU 8136801A AU 8136801 A AU8136801 A AU 8136801A AU 8136801 A AU8136801 A AU 8136801A AU 8136801 A AU8136801 A AU 8136801A
Authority
AU
Australia
Prior art keywords
preventing
conditions
methods
treating diseases
complex carbohydrates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU8136801A
Inventor
Harold G Brown
Karen K Brown
Carol A Cooper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dermal Research Laboratories Inc
Original Assignee
Dermal Research Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dermal Research Laboratories Inc filed Critical Dermal Research Laboratories Inc
Publication of AU8136801A publication Critical patent/AU8136801A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU8136801A 2000-07-31 2001-07-31 Methods of preventing or treating diseases and conditions using complex carbohydrates Pending AU8136801A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22204600P 2000-07-31 2000-07-31
PCT/US2001/041473 WO2002009728A1 (en) 2000-07-31 2001-07-31 Methods of preventing or treating diseases and conditions using complex carbohydrates

Publications (1)

Publication Number Publication Date
AU8136801A true AU8136801A (en) 2002-02-13

Family

ID=22830558

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001281368A Ceased AU2001281368B2 (en) 2000-07-31 2001-07-31 Methods of preventing or treating diseases and conditions using complex carbohydrates
AU8136801A Pending AU8136801A (en) 2000-07-31 2001-07-31 Methods of preventing or treating diseases and conditions using complex carbohydrates

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2001281368A Ceased AU2001281368B2 (en) 2000-07-31 2001-07-31 Methods of preventing or treating diseases and conditions using complex carbohydrates

Country Status (5)

Country Link
EP (1) EP1311276A4 (en)
AU (2) AU2001281368B2 (en)
CA (1) CA2417867C (en)
NZ (2) NZ533078A (en)
WO (1) WO2002009728A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5916565A (en) 1996-03-08 1999-06-29 In Clover, Inc. Product and method for treating joint disorders in vertebrates
WO2002060471A2 (en) * 2001-01-30 2002-08-08 Ich Productions Limited Ligands for receptor-like protein tyrosine phosphatases
ITMI20021866A1 (en) * 2002-08-30 2004-02-29 Luigi Allegra PHARMACEUTICAL PREPARATION IN COLLOIDAL FORM USEFUL IN THE TREATMENT OF SKIN DISEASES.
US7060691B2 (en) * 2002-10-10 2006-06-13 Giuseppe Petrigni Pharmaceutical colloidal preparation useful in the treatment of respiratory diseases
US8519008B2 (en) 2003-01-22 2013-08-27 Purina Animal Nutrition Llc Method and composition for improving the health of young monogastric mammals
US20040161476A1 (en) 2003-02-19 2004-08-19 Hahn Sungtack Samuel Cystitis treatment with high dose chondroitin sulfate
US7511026B2 (en) * 2003-03-25 2009-03-31 Seikagaku Corporation Therapeutic agent for nerve damage
US20070225484A1 (en) * 2006-03-25 2007-09-27 Framroze Bomi P Process for the Isolation and Stabilization of Low-Molecular Weight Aminoglycans from Waste Egg Shells
DE602006008834D1 (en) * 2006-05-11 2009-10-08 Sandra Gobbo BINARY HYALURONIC ACID MIXTURES AND ITS THERAPEUTIC USE
ITMI20061030A1 (en) 2006-05-26 2007-11-27 Altergon Sa NEW COMPOSITION INCLUDING GLYCOSAMINOGLICANS WITH CONTROLLED VISCOSITY AND USE OF SUCH COMPOSITION IN THE THERAPY OF CHRONIC CYSTITIS
DE102006060953A1 (en) * 2006-12-12 2008-08-07 Farco-Pharma Gmbh Synergistic preparation for treating urinary tract inflammation, e.g. cystitis, contains low molecular hyaluronic acid and another glycosaminoglycan, preferably chondroitin sulfate
ES2405314T3 (en) * 2008-05-13 2013-05-30 Apharm S.R.L. Compositions and oral use of glycosaminoglycans
US9241953B2 (en) 2008-05-13 2016-01-26 Apharm S.R.L. Glycosaminoglycan oral use and compositions
TWI383796B (en) * 2009-08-14 2013-02-01 Holy Stone Healthcare Co Ltd Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer
TWI516269B (en) * 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease
FR2959415B1 (en) * 2010-04-30 2012-07-13 Ayawane DERMATOLOGICAL COMPOSITION BASED ON ARGAN OIL AND HYALURONIC ACID.
FI20115631A0 (en) 2011-06-21 2011-06-21 Turun Yliopisto IMMUNOSTIMULATORY COMPOUNDS AND USES THEREOF
ITMI20130117A1 (en) * 2013-01-25 2014-07-26 Gnosis Spa COMPOSITIONS INCLUDING CONDROITIN SULFATE, PROTEOLITHIC ENZYMES AND COMPOUNDS OF SULFIDRYLATES TO IMPROVE THE BIOAVAILABILITY OF CONDROITIN SULFATE
EP3479830B1 (en) * 2016-04-25 2024-09-11 College of Animal Science & Technology, Qingdao Agriculture University Application of small-molecule hyaluronic acid fragment
CN118902993A (en) * 2016-04-25 2024-11-08 惠觅宙 Application of injection containing small-molecule hyaluronic acid
CN108721320A (en) * 2017-04-24 2018-11-02 惠觅宙 The application of micromolecule hyaluronic acid segment
IL293852A (en) * 2019-12-13 2022-08-01 Folium Labs Inc Conjugates containing a carbohydrate polymer and an active ingredient and processes for their preparation
WO2024051848A1 (en) * 2022-09-09 2024-03-14 北京达尔文细胞生物科技有限公司 Pharmaceutical composition for preventing and treating nervous system lesions and application thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1291123C (en) * 1986-03-14 1991-10-22 Abraham Nimrod Heavy metal salts of hyaluronic acid useful as antimicrobial agents
US4808576A (en) * 1986-04-28 1989-02-28 Mobay Corporation Remote administration of hyaluronic acid to mammals
EP0254845A3 (en) * 1986-06-10 1989-04-19 Lescarden Inc. Immune stimulation with chondroitin sulfate
AU7852687A (en) * 1986-08-21 1988-03-08 University Of Texas System, The Glycosaminoglycan derivatives and their use as inhibitors of tumor invasiveness or metastatic profusion
WO1991013624A1 (en) * 1990-03-05 1991-09-19 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Endogenous, suramin-induced, sulfated glycosaminoglycans as anti-cancer agents in humans
ES2090167T3 (en) * 1991-04-18 1996-10-16 Baldacci Lab Spa TOPIC USE OF GLYCOSAMINOGLYCANS IN THE PREVENTION AND TREATMENT OF DISEASES AFFECTING THE CERVICAL VAGINAL TRACT.
KR970705401A (en) * 1994-08-30 1997-10-09 사무엘 시몬 에스큘라이 HYALURONIC ACID AND DERIVATIVES FOR MODULATION OF CELLULAR ACTIVITY FOR ADJUSTING CELL ACTIVITY
CA2175282A1 (en) * 1996-04-29 1997-10-30 Rudolf Edgar Falk Use of forms of hyaluronic acid (ha) for the treatment of cancer
US5929050A (en) * 1998-02-27 1999-07-27 Petito; George D. Chondroitin sulfate composition and method for wound treatment
IT1301994B1 (en) * 1998-08-05 2000-07-20 Jasper Ltd Liability Co HYALURONIC ACID DERIVATIVES.
US6083933A (en) * 1999-04-19 2000-07-04 Stellar International Inc. Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution

Also Published As

Publication number Publication date
AU2001281368B2 (en) 2005-07-28
EP1311276A4 (en) 2007-09-12
CA2417867A1 (en) 2002-02-27
NZ533078A (en) 2006-11-30
NZ524076A (en) 2004-07-30
WO2002009728A1 (en) 2002-02-07
CA2417867C (en) 2012-09-11
EP1311276A1 (en) 2003-05-21

Similar Documents

Publication Publication Date Title
AU8136801A (en) Methods of preventing or treating diseases and conditions using complex carbohydrates
EP1200086A4 (en) Methods for treating or preventing pain and anxiety
AU7186501A (en) Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
EP1267798A4 (en) Treatment of skin damage using polyenylphosphatidylcholine
EP1217963A4 (en) Devices and methods for treating tissue
EP1283702A4 (en) Medical dressing assembly and associated method of using the same
AU1166502A (en) Human ect2 and methods of use
GB9824436D0 (en) Methods of treatment
IL160835A0 (en) Catheter and method of using same
EP1463495A4 (en) Agents and methods for treatment of cancer
AU5754701A (en) Method of using cox-2 inhibitors in the treatment and prevention of ocular cox-2mediated disorders
AU3840802A (en) Methods and compositions for the treatment of diseases of the eye
AU2001240046A1 (en) Method of treating skin conditions
IL138692A0 (en) Treatment and prevention of vascular disease
IL148202A0 (en) Copolymers and methods of treating prion-related diseases
GB0115707D0 (en) Treatment and prevention of lipodermatosclerosis
GB2360453B (en) Treatment of skin conditions
EP1435970A4 (en) Methods of treating skin with diphosphonate derivatives
AU6970101A (en) Method for treatment and prevention of mastitis
GB0008921D0 (en) Method of treatment
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases
EP1190089A4 (en) Methods of treatment using lig 72a and variants thereof
EP1303281A4 (en) Methods of treatment
ZA200103250B (en) The treatment of immunomodulatory related and other diseases or conditions.
GB0016197D0 (en) Treatment and prevention of disease